Literature DB >> 9535457

Lobectomy combined with volume reduction for patients with lung cancer and advanced emphysema.

S R DeMeester1, G A Patterson, R S Sundaresan, J D Cooper.   

Abstract

OBJECTIVE: Early-stage lung cancer is best treated by anatomic pulmonary resection. Patients with lung cancer and severe emphysema are often denied resection or are offered only limited, nonanatomic resections when established pulmonary function criteria for lobectomy are not met. Recently, with the introduction of the volume reduction operation, selected patients with disabling emphysema have undergone excision of approximately 30% of the most destroyed lung tissue and have subsequently demonstrated subjective and objective improvement in pulmonary function. Using these principles, we elected to combine anatomic lobectomy with volume reduction in a select group of patients with both emphysema and lung cancer who would not otherwise be candidates for pulmonary resection.
METHODS: Five patients with severe emphysema and suspected or proven lung cancers, who were poor candidates for anatomic lobectomy by traditional criteria but were good candidates for volume reduction, underwent lobectomy combined with volume reduction of one or more additional lobes.
RESULTS: All five patients having lung volume reduction and anatomic lobectomy for early-stage primary lung cancer did well postoperatively. Furthermore, each patient has demonstrated subjective and objective improvement in respiratory function on serial postoperative studies.
CONCLUSIONS: Selected patients with disabling emphysema and suitable anatomy for volume reduction, who have a lung cancer situated in destroyed lung tissue, may benefit from combined lobectomy and volume reduction. The introduction of the volume reduction operation has added a new factor in the algorithm for the evaluation and treatment of lung cancer in selected patients with advanced emphysema.

Entities:  

Mesh:

Year:  1998        PMID: 9535457     DOI: 10.1016/S0022-5223(98)70334-4

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Surgical treatment for patients with lung cancer complicated by severe pulmonary emphysema.

Authors:  K Hayashi; K Fukushima; Y Sagara; M Takeshita
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  1999-12

Review 2.  Lung transplantation and lung volume reduction surgery versus transplantation in chronic obstructive pulmonary disease.

Authors:  Namrata Patel; Malcolm DeCamp; Gerard J Criner
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

3.  Lobar volume reduction surgery: a method of increasing the lung cancer resection rate in patients with emphysema.

Authors:  J G Edwards; D J Duthie; D A Waller
Journal:  Thorax       Date:  2001-10       Impact factor: 9.139

4.  Multidisciplinary Evaluation of Patients With Suspected Lung Cancer.

Authors:  Kristy Bauman; Douglas Arenberg
Journal:  Clin Pulm Med       Date:  2010-01-01

5.  Video-assisted lobectomy for a lung cancer patient with chronic obstructive pulmonary disease.

Authors:  Kiyoshi Koizumi; Shuji Haraguchi; Tomomi Hirata; Kyoji Hirai; Iwao Mikami; Mitsuhiro Fukushima; Daisuke Okada; Shigeki Yamagishi; Yuki Nakajima; Shigeo Tanaka
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2003-11

6.  Is the initial feasibility of lobectomy for stage I non-small cell lung cancer in severe heterogeneous emphysema justified by long-term survival?

Authors:  Antonio E Martin-Ucar; Khaleel R Fareed; Apostolos Nakas; Paul Vaughan; John G Edwards; David A Waller
Journal:  Thorax       Date:  2007-02-08       Impact factor: 9.139

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.